Iodine I 131 Monoclonal Antibody 81c6

Iodine I 131 Monoclonal Antibody 81c6 Uses, Dosage, Side Effects, Food Interaction and all others data.

Iodine I 131 Monoclonal Antibody 81c6 is under investigation in clinical trial NCT00615186 (Glioblastoma Multiforme (GBM) Locoregional Agent Survival Study - Anti-tenascin Radiolabeled Antibody Therapy).

Trade Name Iodine I 131 Monoclonal Antibody 81c6
Generic Neuradiab
Neuradiab Other Names 81c6, a murine igg2 anti-tenascin monoclonal antibody labeled with iodine 131 (I-131), Anti-tenascin monoclonal antibody 81c6-I-131, Iodine i 131 moab 81c6, Iodine i 131 monoclonal antibody 81c6, Iodine I-131 monoclonal antibody 81c6, Moab, 81c6, murine, iodine-I-131 radiolabeled, to human glioma, Neuradiab
Type
Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Iodine I 131 Monoclonal Antibody 81c6
Iodine I 131 Monoclonal Antibody 81c6

Innovators Monograph

You find simplified version here Iodine I 131 Monoclonal Antibody 81c6


*** Taking medicines without doctor's advice can cause long-term problems.
Share